ArticleCureus2026
Improving Breast Cancer Screening Coverage in Primary Healthcare: A Quality-Improvement Study (2023-2025).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimOrganized breast cancer screening reduces mortality; however, coverage within our primary healthcare (PHC) network was substantially below benchmarks. Barriers included limited awareness, fragmented workflows, suboptimal use of electronic systems, and constrained diagnostic capacity. Screening delivery relied on opportunistic identification rather than systematic recall, resulting in missed opportunities, limited performance monitoring, and prolonged diagnostic pathways. This study aimed to increase breast cancer screening coverage among eligible women aged 40-69 years attending PHC clinics from 1.0% in August 2023 to at least 76% by September 2025 through: (1) systematic identification of eligible women using electronic health records (EHR)-based prompts and recall systems; (2) increased completion of screening mammograms; (3) timely diagnostic follow-up (≤14 days); and (4) minimal disruption to clinical workflow.
methodsA quality-improvement (QI) initiative was conducted from August 2023 to October 2024 using the Institute for Healthcare Improvement Model for Improvement and sequential Plan-Do-Study-Act (PDSA) cycles. A multi-disciplinary team reviewed weekly and monthly reports tracking mammography requests, completions, Breast Imaging Reporting and Data System (BI-RADS) results, and waiting times. Although active implementation concluded in October 2024, outcomes were monitored through September 2025 to assess sustainability. Four PDSA cycles addressed as follows: (1) staff awareness and readiness, (2) structured patient recall using electronic health record-generated eligibility lists and outreach, (3) performance transparency via dashboards and feedback, and (4) workflow integration with periodic audits to support sustainability. The primary outcome was screening coverage. Secondary outcomes included BI-RADS distribution and confirmed malignancies. Balancing measures were mammography waiting time and physician perceptions.
resultsDocumented screening coverage increased from 1.0% (n=49) in August 2023 to 70% (n≈3,400 of 4,857 eligible women) by September 2025. During the project period, a total of 1,652 screening mammograms were completed. Among completed mammograms, 68.2% (n=1,127) were BI-RADS 1-2, 18.9% (n=312) BI-RADS 0, 11.6% (n=192) BI-RADS 3, and 1.3% (n=21) BI-RADS 4-5, yielding 11 confirmed malignancies. Waiting times improved following capacity adjustments. Physician survey responses (n=36) indicated good acceptability and perceived feasibility within routine practice.
conclusionsA multi-component, data-driven QI strategy integrated into PHC workflows was feasible and associated with substantial and sustained improvement in breast cancer screening coverage while maintaining timely diagnostic follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.